Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer
This study is the first to use an adaptive design that tailors treatment in the neoadjuvant/adjuvant setting of patients with HER2-positive early...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pharmaceuticals | Study